Kosonen Jussi, Kronberg Leif
Laboratory of Organic Chemistry, Abo Akademi University, 20500 Abo, Finland.
Environ Sci Pollut Res Int. 2009 Jul;16(5):555-64. doi: 10.1007/s11356-009-0144-2. Epub 2009 Apr 1.
BACKGROUND, AIM AND SCOPE: Each year, large quantities of pharmaceuticals are consumed worldwide for the treatment and prevention of human and animal diseases. Although the drugs and the metabolites observed in the wastewaters and in the environment are present at concentrations several orders of magnitude lower than the concentrations required to exert their effects in humans or animals, their long-term impact on the environment is commonly not known. In this study, the occurrence of six antihistamines, which are used for the relief of allergic reactions such as hay fever, was determined in sewage treatment plants wastewaters and in recipient river waters.
The occurrence of the antihistamines cetirizine, acrivastine, fexofenadine, loratadine, desloratadine and ebastine in sewage treatment plants wastewaters and in recipient river waters was studied. The analytical procedure consisted of solid-phase extraction of the water samples followed by liquid chromatography separation and detection by a triple-quadrupole mass spectrometer in the multiple reaction mode.
Cetirizine, acrivastine and fexofenadine were detected in both influent and effluent wastewater samples at concentration levels ranging from about 80 to 220 ng/L, while loratadine, desloratadine and ebastine could not be detected in any samples. During sewage treatment, the concentration of the antihistamines dropped by an average of 16-36%. Furthermore, elevated concentrations of antihistamines were observed in samples collected during the season of most intensive plant pollen production, i.e. in May. In the river water samples, the relative pattern of occurrence of cetirizine, acrivastine and fexofenadine was similar to that in the wastewater samples; although the concentration of the compounds was substantially lower (4-11 ng/L). The highest concentrations of the studied drugs were observed near the discharging point of the sewage treatment plant.
The highest concentrations of antihistamines in STP wastewaters correlate with the outbreak of allergic reaction caused by high amounts of plant pollens in the air. The analysis results of the river water samples show that the antihistamines are carried far away from the effluent discharge points. They may account for a part of the mix of pharmaceuticals and of pharmaceutical metabolites that occur downstream of STPs.
Antihistamines are poorly degraded/eliminated under the biological treatment processes applied in the wastewater treatment plants and, consequently, they are continuously being discharged along with other drugs to the aquatic environment.
As a huge quantity and variety of drugs and their metabolites are continuously discharged to rivers and the sea, the compounds should be considered as contaminants that may possess risks to the aquatic ecosystem. Further studies are urgently needed on the environmental fate of the antihistamines and other pharmaceuticals in the aquatic environment. These studies should be concerned with the stability of the compounds, their transformation reactions and the identity of the transformation products, the distribution of drugs and their uptake and effects in organisms. On the basis of these studies, the possible environmental hazards of pharmaceuticals may be assessed.
背景、目的和范围:每年,全球都会消耗大量药物用于治疗和预防人类及动物疾病。尽管在废水和环境中观察到的药物及其代谢物的浓度比在人类或动物体内发挥作用所需的浓度低几个数量级,但其对环境的长期影响通常尚不清楚。在本研究中,测定了污水处理厂废水和受纳河水体中六种用于缓解诸如花粉热等过敏反应的抗组胺药的存在情况。
研究了污水处理厂废水和受纳河水体中抗组胺药西替利嗪、阿伐斯汀、非索非那定、氯雷他定、地氯雷他定和依巴斯汀的存在情况。分析程序包括对水样进行固相萃取,然后通过液相色谱分离,并采用三重四极杆质谱仪在多反应模式下进行检测。
在进水和出水废水样品中均检测到西替利嗪、阿伐斯汀和非索非那定,浓度范围约为80至220 ng/L,而在任何样品中均未检测到氯雷他定、地氯雷他定和依巴斯汀。在污水处理过程中,抗组胺药的浓度平均下降了16 - 36%。此外,在植物花粉产量最高的季节(即5月)采集的样品中观察到抗组胺药浓度升高。在河水样品中,西替利嗪、阿伐斯汀和非索非那定的相对出现模式与废水样品中的相似;尽管这些化合物的浓度要低得多(4 - 11 ng/L)。在所研究药物的最高浓度出现在污水处理厂排放点附近。
污水处理厂废水中抗组胺药的最高浓度与空气中大量植物花粉引起的过敏反应爆发相关。河水样品的分析结果表明,抗组胺药被带离废水排放点很远。它们可能是污水处理厂下游出现的药物和药物代谢物混合物的一部分。
在污水处理厂应用的生物处理过程中,抗组胺药降解/去除效果不佳,因此它们不断与其他药物一起排放到水生环境中。
由于大量种类繁多的药物及其代谢物不断排放到河流和海洋中,这些化合物应被视为可能对水生生态系统具有风险的污染物。迫切需要进一步研究抗组胺药和其他药物在水生环境中的环境归宿。这些研究应关注化合物的稳定性、它们的转化反应以及转化产物的特性、药物的分布及其在生物体中的吸收和影响。基于这些研究,可以评估药物可能的环境危害。